Andrew Jones

Andrew Jones is an experienced professional in the field of quality assurance and compliance, currently serving as Vice President of Commercial Quality at Iovance Biotherapeutics, Inc. Previously, Andrew held various leadership roles at GSK, including Head of Cell and Gene Therapies QA, Head of Product Quality for Biopharm and Sterile Products, and Head of Quality for the Biopharm Supply Chain. Andrew also served as Head of Quality at Intercell USA, President of Jones, LLC, and Director of Compliance, NPI at Johnson & Johnson. Andrew's academic credentials include a Post Baccalaureate degree in BECP from The Wharton School and a degree from the University of Delaware.